Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
About
  2. products
  3. biocept model ngs next gen sequencing breast panel liquid biopsy biomarker

Biocept -Model NGS -Next-Gen Sequencing Breast Panel - Liquid Biopsy Biomarker

SHARE

Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support resources.

Most popular related searches
biopsy biomarker
liquid biopsy
advanced sequencing
circulating cancer cell
biopsy
biomarker test
biomarker testing
biomarker
cancer cell
biopsy testing
  • Exclusive, targeted and actionable
  • Cost effective NGS-based solution
  • Turn-around-time (7-10 days upon receipt of specimen in most cases)
  • Sensitivity: 94.1-100% (MAF ≥0.1%)
  • Raw data available for further research
  • Specimen requirements: 8 mLs of peripheral blood in CEE-SURE™ or EDTA Tube
PD-L1, PR, ER, and AR expression testing available through Target Selector™ Circulating Tumor Cell (CTC) testing.